Pharmabiz

AIOCD to organise nationwide pharmacy bandh on May 11 against online pharmacies & doorstep delivery

AIOCD to organise nationwide pharmacy bandh on May 11 against online pharmacies & doorstep delivery: Peethaambaran Kunnathoor ...
Pharmabiz

KDPMA drives leadership excellence to power operational success & navigate evolving regulations

KDPMA drives leadership excellence to power operational success & navigate evolving regulations: Nandita Vijayasimha, Bengaluru Saturday, March 21, 2026, 08:00 Hrs [IST] The Karna ...
Pharmabiz

CSOs ask India to protect public health interests in PABS negotiations under WHO Pandemic Agreement

CSOs ask India to protect public health interests in PABS negotiations under WHO Pandemic Agreement: Our Bureau, New Delhi Saturday, March 21, 2026, 08:00 Hrs [IST] Raising concer ...
Pharmabiz

Rhythm Pharmaceuticals’ setmelanotide receives US FDA approval to treat patients living with acquired hypothalamic obesity

Rhythm Pharmaceuticals’ setmelanotide receives US FDA approval to treat patients living with acquired hypothalamic obesity: Boston Saturday, March 21, 2026, 18:00 Hrs [IST] Rhyt ...
Pharmabiz

HDMA seeks Centre's intervention to address issues arising from West Asia crisis

HDMA seeks Centre's intervention to address issues arising from West Asia crisis: Gireesh Babu, New Delhi Saturday, March 21, 2026, 08:00 Hrs [IST] The Himachal Drug Manufacturers ...
Pharmabiz

Indian hospitals turn to predictive analytics to evaluate patient repayment & treatment pathways

Indian hospitals turn to predictive analytics to evaluate patient repayment & treatment pathways: Nandita Vijayasimha, Bengaluru Saturday, March 21, 2026, 08:00 Hrs [IST] Indian h ...
Pharmabiz

Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes

Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes: Our Bureau, Mumbai Saturday, March 21, 2026, 13:30 Hrs [IST] Dr Red ...
Pharmabiz

Biohaven completes patient enrolment in phase 2 obesity study with taldefgrobep alfa, a novel myostatin-activin pathway inhibitor

Biohaven completes patient enrolment in phase 2 obesity study with taldefgrobep alfa, a novel myostatin-activin pathway inhibitor: New Haven, Connecticut Saturday, March 21, 2026, ...
Pharmabiz

Sun Pharma introduces semaglutide injection under the brand names, Noveltreat and Sematrinity in India

Sun Pharma introduces semaglutide injection under the brand names, Noveltreat and Sematrinity in India: Our Bureau, Mumbai Saturday, March 21, 2026, 14:15 Hrs [IST] Sun Pharmaceut ...
Pharmabiz

New PRIME tools to accelerate development of medicines in the EU

New PRIME tools to accelerate development of medicines in the EU: Amsterdam, The Netherlands Saturday, March 21, 2026, 14:00 Hrs [IST] EMA launched three major new features of PRI ...
Pharmabiz

Macau Drug Administration approves Belief Pharmaceuticals’ haemophilia B gene therapy drug, Popidacoji injection

Macau Drug Administration approves Belief Pharmaceuticals’ haemophilia B gene therapy drug, Popidacoji injection: Shanghai, China Saturday, March 21, 2026, 17:00 Hrs [IST] Belie ...
Pharmabiz

Kythera Labs inks partnership with Doceree to improve data-driven engagement with healthcare professionals

Kythera Labs inks partnership with Doceree to improve data-driven engagement with healthcare professionals: Franklin, Tennessee Saturday, March 21, 2026, 16:00 Hrs [IST] Kythera L ...